Karl E. Anderson

13.6k total citations
233 papers, 8.7k citations indexed

About

Karl E. Anderson is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karl E. Anderson has authored 233 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Molecular Biology, 60 papers in Pediatrics, Perinatology and Child Health and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karl E. Anderson's work include Porphyrin Metabolism and Disorders (102 papers), Heme Oxygenase-1 and Carbon Monoxide (82 papers) and Neonatal Health and Biochemistry (56 papers). Karl E. Anderson is often cited by papers focused on Porphyrin Metabolism and Disorders (102 papers), Heme Oxygenase-1 and Carbon Monoxide (82 papers) and Neonatal Health and Biochemistry (56 papers). Karl E. Anderson collaborates with scholars based in United States, Vietnam and Switzerland. Karl E. Anderson's co-authors include Attallah Kappas, Allan H. Conney, Herbert L. Bonkovsky, James J. Grady, Alvito P. Alvares, Manubai Nagamani, Robert J. Desnick, D. Montgomery Bissell, Eugene J. Pantuck and Joseph R. Bloomer and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Karl E. Anderson

224 papers receiving 8.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl E. Anderson United States 54 3.8k 1.5k 989 970 962 233 8.7k
Gérard Siest France 61 4.1k 1.1× 1.2k 0.8× 1.1k 1.1× 459 0.5× 1.2k 1.2× 519 14.5k
Lesley J. Scott New Zealand 57 3.1k 0.8× 551 0.4× 697 0.7× 1.2k 1.2× 457 0.5× 333 12.9k
Greg L. Plosker New Zealand 57 1.9k 0.5× 734 0.5× 596 0.6× 691 0.7× 403 0.4× 261 10.1k
Émile Lévy Canada 61 4.1k 1.1× 1.1k 0.8× 719 0.7× 679 0.7× 1.5k 1.5× 357 13.1k
Kay Brune Germany 65 3.0k 0.8× 965 0.7× 426 0.4× 390 0.4× 702 0.7× 345 14.5k
Ronald J. Sokol United States 72 2.3k 0.6× 1.2k 0.8× 427 0.4× 3.9k 4.1× 925 1.0× 314 14.9k
Hiroshi Sato Japan 49 2.6k 0.7× 556 0.4× 931 0.9× 675 0.7× 658 0.7× 319 10.9k
Lee S. Simon United States 49 1.5k 0.4× 576 0.4× 823 0.8× 577 0.6× 1.2k 1.2× 196 15.7k
Julie A. Ross United States 46 2.9k 0.8× 2.3k 1.6× 770 0.8× 909 0.9× 571 0.6× 175 9.6k
Claudio Napoli Italy 70 6.2k 1.7× 1.5k 1.0× 1.2k 1.2× 2.0k 2.1× 1.2k 1.2× 450 20.5k

Countries citing papers authored by Karl E. Anderson

Since Specialization
Citations

This map shows the geographic impact of Karl E. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl E. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl E. Anderson more than expected).

Fields of papers citing papers by Karl E. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl E. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl E. Anderson. The network helps show where Karl E. Anderson may publish in the future.

Co-authorship network of co-authors of Karl E. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Karl E. Anderson. A scholar is included among the top collaborators of Karl E. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl E. Anderson. Karl E. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moghe, Akshata, et al.. (2025). Porphyria Diagnostics Part 2: Essential Biochemical Testing for Diagnosis of the Porphyrias. Current Protocols. 5(2). e70092–e70092.
2.
Salamanca, Rafael Enrı́quez de, et al.. (2024). Exploring current and emerging therapies for porphyrias. Liver International. 44(9). 2174–2190. 4 indexed citations
3.
Sardh, Eliane, Manisha Balwani, David C. Rees, et al.. (2024). Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study. Orphanet Journal of Rare Diseases. 19(1). 365–365. 1 indexed citations
4.
Leaf, Rebecca Karp, Hetanshi Naik, Sarina B. Elmariah, et al.. (2024). Afamelanotide for Treatment of the Protoporphyrias: Impact on Quality of Life and Laboratory Parameters in a US Cohort. Life. 14(6). 689–689. 2 indexed citations
5.
Zhu, Junjie, Fu‐Ying Qin, Saifei Lei, et al.. (2024). Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria. Nature Communications. 15(1). 10557–10557. 1 indexed citations
6.
Bonkovsky, Herbert L., et al.. (2023). Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C. Digestive Diseases and Sciences. 68(6). 2738–2746. 4 indexed citations
7.
Hussain, Zahir, Qian Qi, Junjie Zhu, Karl E. Anderson, & Xiaochao Ma. (2023). Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics. Pharmacology & Therapeutics. 248. 108487–108487. 25 indexed citations
8.
Levy, Cynthia, Karl E. Anderson, Manisha Balwani, et al.. (2023). PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA. HemaSphere. 7(S3). e904346e–e904346e. 1 indexed citations
9.
Anderson, Karl E., Robert J. Desnick, M F Stewart, Paolo Ventura, & Herbert L. Bonkovsky. (2021). Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features That Should Prompt Specific Diagnostic Testing. The American Journal of the Medical Sciences. 363(1). 1–10. 6 indexed citations
10.
Stein, Penelope E., D. Rees, Karl E. Anderson, et al.. (2020). A phase 1/2 open label extension study of givosiran, an investigational RNAi therapeutic, in patients with acute intermittent porphyria. Journal of Hepatology. 73. S553–S554. 9 indexed citations
11.
Dickey, Amy K., Corbin Quick, Sarah Ducamp, et al.. (2020). Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria. Genetics in Medicine. 23(1). 140–148. 22 indexed citations
12.
Bonkovsky, Herbert L., Vinaya C. Maddukuri, Cemal Yazıcı, et al.. (2014). Acute Porphyrias in the USA: Features of 108 Subjects from Porphyrias Consortium. The American Journal of Medicine. 127(12). 1233–1241. 173 indexed citations
13.
14.
Wang, Keyang, Kathleen M. Holtz, Karl E. Anderson, et al.. (2005). Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine. Vaccine. 24(12). 2176–2185. 119 indexed citations
15.
Anderson, Karl E., et al.. (2005). Effect of a Soymilk Supplement Containing Isoflavones on Urinary F2 Isoprostane Levels in Premenopausal Women. Nutrition and Cancer. 53(1). 73–81. 13 indexed citations
16.
Anderson, Karl E., et al.. (1991). Diet and cimetidine induce comparable changes in theophylline metabolism in normal subjects. Hepatology. 13(5). 941–946. 15 indexed citations
17.
Pantuck, Eugene J., et al.. (1991). Effects of protein and carbohydrate content of diet on drug conjugation. Clinical Pharmacology & Therapeutics. 50(3). 254–258. 17 indexed citations
18.
Fischbein, Alf, Susan M. Daum, Bernard Davidow, et al.. (1978). Lead hazard among ironworkers. Dismantling lead-painted elevated subway line in New York City.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 78(8). 1250–9. 8 indexed citations
19.
Alvares, Alvito P., Allan H. Conney, Karl E. Anderson, & A. Kappas. (1976). Interaction between nutritional factors and drug biotransformations in man. 18(2). 1 indexed citations
20.
Sun, Shuguo, et al.. (1974). Hepatocellular ultrastructure in asymptomatic hepatitis B antigenemia. Archives of Pathology & Laboratory Medicine. 97(6). 373–379. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gérard Siest Breakdown of academic impact, for papers by Lesley J. Scott Breakdown of academic impact, for papers by Greg L. Plosker Breakdown of academic impact, for papers by Émile Lévy Breakdown of academic impact, for papers by Kay Brune Breakdown of academic impact, for papers by Ronald J. Sokol Breakdown of academic impact, for papers by Hiroshi Sato Breakdown of academic impact, for papers by Lee S. Simon Breakdown of academic impact, for papers by Julie A. Ross Breakdown of academic impact, for papers by Claudio Napoli
Rankless by CCL
2026